Dated: Wednesday April 26th 2023
VIB, Flanders’ leading life sciences institute, and UGent are leading a European Network that has secured a grant of more than 8 million euros to develop a new vaccine technology against bacterial infections. In a consortium called “Baxerna,” VIB, UGent, Ghent University Hospital, VUB, ULB, the Pasteur Institute, the Radboud Medical Center and the Karolinska Institute, led by Profs. Lennart Martens and Francis Impens (VIB-Ghent University Center for Medical Biotechnology) will search for new antibacterial mRNA vaccines as a preventive tool in the fight against antimicrobial resistance. This will initially focus on pathogens such as Mycobacterium tuberculosis, Mycobacterium ulcerans and Acinetobacter baumannii. The first clinical studies will take place at Ghent University Hospital in collaboration with the Center for Vaccinology (CEVAC).
Read the full article:
https://flanders.bio/en/news/vib-and-ghent-university-mrna-vaccines